INCOME STATEMENT
Lincoln Pharmaceuticals Ltd.
BSE
Jun 16, 09:51
570.00
-15.45 ( -2.64%)
Volume
1181
Prev. Close
585.45
Open Price
589.45
Bid Price(Qty.)
569.25 (3)
Offer Pr.(Qty.)
571.10 (20)
NSE
Jun 16, 09:39
571.70
-14.25 ( -2.43%)
Volume
17381
Prev. Close
585.95
Open Price
582.50
Bid Price(Qty.)
571.00 (4)
Offer Pr.(Qty.)
572.00 (1)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE405C01035
|
Market Cap. ( ₹ in Cr. )
|
1145.10
|
P/BV
|
1.79
|
Book Value ( ₹ )
|
319.16
|
|
BSE Code
|
531633
|
52 Week High/Low ( ₹ )
|
980/499
|
FV/ML
|
10/1
|
P/E(X)
|
13.91
|
|
NSE Code
|
LINCOLNEQ
|
Book Closure
|
30/09/2024
|
EPS ( ₹ )
|
41.11
|
Div Yield (%)
|
0.31
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 623.23 | 571.22 | 504.95 | 468.16 | 403.89 |
| Other Operating Revenues | 0.00 | 9.33 | 5.35 | 3.92 | 9.17 |
| Total Operating Revenues | 623.23 | 580.55 | 510.31 | 472.08 | 413.06 |
| | | | | | |
| Other Income | 22.48 | 34.42 | 22.48 | 10.00 | 6.77 |
| Total Revenue | 645.71 | 614.97 | 532.79 | 482.08 | 419.82 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 213.94 | 201.12 | 177.00 | 158.48 | 95.50 |
| Purchase Of Stock-In Trade | 68.54 | 82.91 | 68.64 | 73.67 | 104.00 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 8.84 | -5.70 | -4.24 | -13.57 | 1.35 |
| Employee Benefit Expenses | 112.45 | 102.90 | 93.16 | 70.47 | 56.47 |
| Finance Costs | 1.88 | 1.46 | 2.03 | 1.45 | 1.44 |
| Depreciation And Amortisation Expenses | 12.90 | 10.62 | 9.17 | 8.09 | 5.67 |
| Other Expenses | 117.96 | 99.40 | 86.59 | 87.56 | 74.38 |
| Total Expenses | 536.52 | 492.73 | 432.34 | 386.15 | 338.81 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 109.19 | 122.24 | 100.46 | 95.93 | 81.01 |
| | | | | | |
| Profit/Loss Before Tax | 109.19 | 122.24 | 100.46 | 95.93 | 81.01 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 26.84 | 25.21 | 24.73 | 24.50 | 20.22 |
| Deferred Tax | 0.00 | 3.49 | 1.59 | 0.72 | 0.56 |
| Tax For Earlier Years | 0.00 | 0.24 | 1.24 | 1.36 | -0.18 |
| Total Tax Expenses | 26.84 | 28.94 | 27.56 | 26.57 | 20.61 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 82.35 | 93.30 | 72.90 | 69.36 | 60.41 |
| | | | | | |
| Profit/Loss From Continuing Operations | 82.35 | 93.30 | 72.90 | 69.36 | 60.41 |
| | | | | | |
| Profit/Loss For The Period | 82.35 | 93.30 | 72.90 | 69.36 | 60.41 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 30.20 |
| Diluted EPS (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 30.20 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 3.00 | 3.00 | 3.00 | 0.00 |
| Equity Dividend Rate (%) | 18.00 | 18.00 | 15.00 | 15.00 | 15.00 |